Exelixis
EXEL
#1553
Rank
NZ$19.23 B
Marketcap
$68.72
Share price
1.49%
Change (1 day)
89.06%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $86.43 NZD on 2000-07-26

Lowest end of day price: $2.26 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$70.76 0.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
$104.16 0.17%๐Ÿ‡ซ๐Ÿ‡ท France
$167.13 0.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$110.76 3.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$574.52 0.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$294.31 0.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$46.75-0.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.90-4.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.32 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA